US Drug Maker Hit With Three Billion Dollar Fine

Jul 02, 2012

By Scott Walker

Share on

A major US drug manufacturer has been hit with the highest penalty ever paid to the US government in a case of health fraud.

Glaxosmithkline will have to pay three billion dollars and plead guilty for promoting two of its anti-depression drugs …. Paxil and Wellbutrin … for other uses that were not authorized by the government. It’s a practice known as off-label marketing.

The company also failed to report side effects of its diabetes drug, Avandia.

A spokesman says the government wanted to hit Glaxosmithkline with as heavy a payment as possible because drug companies tend to view fines as the cost of doing business.

Advertise With Us

To learn about advertising opportunities with Zoomer Radio use the link below:

Join Our Fan Club
Coverage Area
Downtown Toronto
Toronto HD
96.3 HD-2
Kingston to Windsor, Parry Sound to Pittsburgh
ZoomerRadio Logo

Recently Played: